Last Price
0.042
Today's Change
+0.001 (2.43%)
Day's Change
0.039 - 0.042
Trading Volume
3,515,700
Overview
Market Cap
31 Million
Shares Outstanding
745 Million
Avg Volume
2,994,686
Avg Price (50 Days)
0.04
Avg Price (200 Days)
0.05
PE Ratio
-1.40
EPS
-0.03
Earnings Announcement
01-Nov-2024
Previous Close
0.04
Open
0.04
Day's Range
0.039 - 0.042
Year Range
0.028 - 0.1075
Trading Volume
3,515,700
Price Change Highlight
1 Day Change
2.44%
5 Day Change
5.00%
1 Month Change
0.00%
3 Month Change
11.90%
6 Month Change
-27.81%
Ytd Change
-44.00%
1 Year Change
-58.00%
3 Year Change
-94.81%
5 Year Change
-96.28%
10 Year Change
-96.28%
Max Change
-96.28%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
Australian Court Upholds Ruling Against ANZ in A$2.5b Share Issue Case
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
